Evidence-Based Medicine Guidelines
First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"First-trimester Use of Selective Serotonin-reuptake Inhibitors and the Risk of Birth Defects." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/455221/all/First_trimester_use_of_selective_serotonin_reuptake_inhibitors_and_the_risk_of_birth_defects.
First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/455221/all/First_trimester_use_of_selective_serotonin_reuptake_inhibitors_and_the_risk_of_birth_defects. Accessed March 17, 2025.
First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/455221/all/First_trimester_use_of_selective_serotonin_reuptake_inhibitors_and_the_risk_of_birth_defects
First-trimester Use of Selective Serotonin-reuptake Inhibitors and the Risk of Birth Defects [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 March 17]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/455221/all/First_trimester_use_of_selective_serotonin_reuptake_inhibitors_and_the_risk_of_birth_defects.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects
ID - 455221
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/455221/all/First_trimester_use_of_selective_serotonin_reuptake_inhibitors_and_the_risk_of_birth_defects
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
